FONAR Market Cap

FONAR has a market cap or net worth of $101.59 million as of December 3, 2024. Its market cap has decreased by -11.66% in one year.

Market Cap

101.59M

Enterprise Value

79.82M

1-Year Change

-11.66%

Ranking

#4067

Market Cap Chart

Since December 1, 1998, FONAR's market cap has decreased from $107.60M to $101.59M, a decrease of -5.59%. That is a compound annual growth rate of -0.22%.

Market Cap History

Date	Market Cap	% Change
Dec 2, 2024	106.90M	-20.04%
Dec 29, 2023	133.70M	15.36%
Dec 30, 2022	115.90M	11.55%
Dec 31, 2021	103.90M	-12.39%
Dec 31, 2020	118.60M	-11.82%
Dec 31, 2019	134.50M	-1.39%
Dec 31, 2018	136.40M	-16.01%
Dec 29, 2017	162.40M	29.61%
Dec 30, 2016	125.30M	12.88%
Dec 31, 2015	111.00M	65.92%
Dec 31, 2014	66.90M	-50.66%
Dec 31, 2013	135.60M	372.47%
Dec 31, 2012	28.70M	163.30%
Dec 30, 2011	10.90M	43.42%
Dec 31, 2010	7.60M	-13.64%
Dec 31, 2009	8.80M	91.30%
Dec 31, 2008	4.60M	-84.19%
Dec 31, 2007	29.10M	-20.71%
Dec 29, 2006	36.70M	-54.91%
Dec 30, 2005	81.40M	-53.00%
Dec 31, 2004	173.20M	53.41%
Dec 31, 2003	112.90M	25.58%
Dec 31, 2002	89.90M	8.57%
Dec 31, 2001	82.80M	-4.50%
Dec 29, 2000	86.70M	-20.09%

View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Assembly Biosciences	109.07M
Coya Therapeutics	108.94M
Regulus Therapeutics	108.08M
Akoya Biosciences	107.55M
Anixa Biosciences	104.58M
Karyopharm Therapeutics	103.32M
Veru Inc.	101.72M
Avalo Therapeutics	101.50M

Market Cap Rankings